ARCHIVES

In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished

This article is from The Cancer Letter archive.

Vol. 14 No. 07 | February 12, 1988

Download PDF Visit The Full Archive

Related Articles

NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies

October 18, 1974

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

Program Announcement In Preventative Oncology

May 21, 1982

Agents Not Indicated In Curative Setting.

August 8, 2008

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

FDA To Limit Radiation Doses from Medical Imaging

February 12, 2010